Parallel Advisors’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-456
Closed -$2.66K 3736
2025
Q1
$2.66K Sell
456
-500
-52% -$2.63K ﹤0.01% 2894
2024
Q4
$3.56K Buy
+956
New +$4.41K ﹤0.01% 2761
2024
Q3
Sell
-296
Closed -$2.49K 3484
2024
Q2
$2.49K Buy
296
+223
+305% +$2.38K ﹤0.01% 2747
2024
Q1
$1.05K Buy
73
+1
+1% +$17 ﹤0.01% 2924
2023
Q4
$1.55K Sell
72
-20
-22% -$357 ﹤0.01% 2860
2023
Q3
$1.77K Buy
+92
New +$1.96K ﹤0.01% 2860
2023
Q2
Sell
-34
Closed -$1.23K 3549
2023
Q1
$1.23K Buy
+34
New +$1.19K ﹤0.01% 2906
2022
Q4
Sell
-7
Closed 3546
2022
Q3
$0 Buy
7
+1
+17% +$46 ﹤0.01% 3556
2022
Q2
$0 Sell
6
-44
-88% -$2.42K ﹤0.01% 3415
2022
Q1
$4K Sell
50
-267
-84% -$19.2K ﹤0.01% 2419
2021
Q4
$26K Buy
317
+262
+476% +$26.3K ﹤0.01% 1665
2021
Q3
$6K Buy
+55
New +$7.2K ﹤0.01% 2313
2018
Q3
Sell
-67
Closed -$5K 2316
2018
Q2
$5K Hold
67
﹤0.01% 1629
2018
Q1
$6K Hold
67
﹤0.01% 1511
2017
Q4
$5K Hold
67
﹤0.01% 1607
2017
Q3
$5K Hold
67
﹤0.01% 1618
2017
Q2
$6K Hold
67
﹤0.01% 1556
2017
Q1
$6K Hold
67
﹤0.01% 1446
2016
Q4
$5K Buy
+67
New +$5.74K ﹤0.01% 1393

Other funds holding NVRO

Parallel Advisors's NVRO Position: Q2 2025 in Review

Parallel Advisors sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 456 shares — an estimated $2.66K sold.

Parallel Advisors first reported a position in NVRO in Q4 2016 and held it in 19 quarters. The position peaked at $26K in Q4 2021. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

  • Parallel Advisors reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
  • Parallel Advisors sold 456 NEVRO CORP. shares in Q2 2025, an estimated $2.66K.
  • Parallel Advisors first reported a position in NEVRO CORP. in Q4 2016 and held it in 19 quarters.
  • Parallel Advisors's NEVRO CORP. position peaked at $26K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.